(Q69808036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

cytomegalovirus retinitis

5 October 2019

main subject

1 reference

J Orellana

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

S A Teich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

A H Friedman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

F Lerebours

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J Winterkorn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

D Mildvan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 July 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

831-838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Adult cytomegalic inclusion retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Retinal Aneurysms in Adult Cytomegalovirus Retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Opportunistic infection complicating acquired immune deficiency syndrome. Clinical features of 25 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Parenterally administered acyclovir for viral retinitis associated with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Cytomegalovirus retinitis in a young homosexual male with acquired immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Culture-proven Cytomegalovirus Retinitis in a Homosexual Man with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Ocular findings in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Alpha-interferon administration in cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Clinical and histologic findings in opportunistic ocular infections. Part of a new syndrome of acquired immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Viral particles in the conjunctiva of a patient with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2887%2933536-5

7 January 2021

10.1016/S0161-6420(87)33536-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2821466%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference